Bitget App
Trade smarter
XRP News Today: XRP's Tactical Ascent: Companies Accumulate Digital Asset as a Safeguard Against Macroeconomic Risks

XRP News Today: XRP's Tactical Ascent: Companies Accumulate Digital Asset as a Safeguard Against Macroeconomic Risks

Bitget-RWA2025/11/02 07:52
By:Bitget-RWA

- XRP adoption surges as corporations build treasuries to hedge macroeconomic risks, led by $500M+ investments from Trident Digital, Webus, and VivoPower. - Evernorth becomes largest XRP treasury holder after $1B merger, listing as XRPN on Nasdaq to institutionalize XRP exposure. - Ripple accelerates XRP integration via $1B GTreasury acquisition and regulatory partnerships, positioning XRP for cross-border payments and DeFi. - Upcoming Swell event will highlight XRP's strategic role in supply chain and ass

Institutional interest in digital assets is rapidly increasing, with

emerging at the forefront as more organizations dedicate capital to establish XRP-based treasuries. This movement, known as Digital Asset Treasuries (DATs), has accelerated in 2025, fueled by significant investments from global enterprises. A notable milestone was reached in June when Singapore’s Trident Digital launched a $500 million XRP treasury, soon followed by Webus International’s $300 million initiative to back its chauffeur payment platform with XRP holdings. More recently, VivoPower International from Saudi Arabia revealed a $121 million XRP treasury, highlighting the expanding international interest.

The most notable milestone occurred in October, when Evernorth—a publicly traded company created through a $1 billion merger with Armada Acquisition Corp II—became the largest holder of XRP treasuries. Evernorth’s ticker,

, is now listed on Nasdaq, further cementing XRP’s presence in institutional investment portfolios. Ripple’s CTO, David Schwartz, who now serves as a strategic advisor to Evernorth, is set to co-lead a session at the Swell conference on Nov. 4-5, where he will explore the future of DATs and XRP. Schwartz, having recently transitioned from daily operations at Ripple to a board position, highlighted his involvement in guiding the long-term direction of both organizations.

Ripple’s acquisition of GTreasury—a Chicago fintech company specializing in treasury management—for $1 billion, further demonstrates its dedication to broadening XRP’s practical applications. This acquisition fits within the wider industry push to merge blockchain technology with conventional financial systems. Industry experts point out that DATs represent more than speculative plays; they mark a deliberate move by companies to diversify reserves and mitigate risks from economic instability.

The expansion of the XRP ecosystem is also being propelled by clearer regulatory guidelines. Ripple’s partnerships with Evernorth and other firms have facilitated compliance, paving the way for greater corporate involvement. For example, Evernorth’s merger agreement with Armada Acquisition Corp II was crafted to comply with U.S. securities regulations while enhancing institutional access to XRP.

Industry watchers expect increased activity at the upcoming Swell conference, where Ripple’s executives will discuss new alliances and technological progress. Schwartz is anticipated to share perspectives on XRP’s utility in international payments and decentralized finance (DeFi), areas where the XRP Ledger’s efficiency and low transaction costs offer distinct benefits. The event will also showcase Ripple’s broader ambitions for DATs, including their potential in supply chain solutions and asset tokenization.

Nevertheless, there are hurdles ahead. Some skeptics warn that the rapid expansion of DATs could attract regulatory attention if oversight fails to keep pace. Additionally, fluctuations in the market and broader economic shifts, such as changing interest rates, could influence institutional demand for digital assets. Still, advocates maintain that DATs reflect a strategic, long-term approach, with businesses viewing XRP as a core reserve asset rather than a speculative holding.

With the Swell conference on the horizon, both the XRP community and financial sector are watching for tangible progress in DAT adoption. At present, the prevailing momentum indicates that XRP is well-placed to benefit from the next wave of institutional crypto adoption.

0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Arm's Low-Power Architectures Overcome AI Energy Constraints, Fuel 34% Growth in Revenue

- Arm Holdings reported $1.14B Q3 revenue, 34% YoY growth surpassing forecasts, driven by AI/data center demand. - Royalty revenue rose 21% to $620M while licensing revenue jumped 56% to $515M, reflecting strong IP adoption. - Strategic shift to develop full-chip solutions via Compute Sub Systems aims to compete with Nvidia/Amazon in AI hardware. - Parent company SoftBank explored Arm-Marvell merger to strengthen AI infrastructure, highlighting industry consolidation trends. - 20 "buy" ratings and $155 pri

Bitget-RWA2025/11/06 08:30
Arm's Low-Power Architectures Overcome AI Energy Constraints, Fuel 34% Growth in Revenue

Fed Faces a Choice: Boost Growth or Curb Mounting Debt?

- U.S. household debt hit $18.59 trillion in Q3 2025, driven by rising credit card, student loan, and home equity debt with delinquency rates at multi-year highs. - The Fed initiated rate cuts amid slowing job growth but faces a dilemma: easing economic strain risks inflating a consumer debt bubble while tightening worsens defaults. - Retailers, banks, and auto lenders face fallout as discretionary spending declines and loan defaults rise, while essential goods and debt collectors see increased demand. - P

Bitget-RWA2025/11/06 08:30
Fed Faces a Choice: Boost Growth or Curb Mounting Debt?

Antitrust Battle Ignites as Pfizer Obstructs Novo's $9 Billion Metsera Acquisition

- Novo Nordisk's $9B Metsera acquisition faces Pfizer lawsuits alleging antitrust violations and breach of contract under U.S. antitrust laws. - Pfizer claims the deal delays GLP-1 competition and binds Metsera to restrictive covenants, while Novo dismisses allegations as "baseless" and confident in antitrust compliance. - Novo cuts $8B annual costs, launches Wegovy pill, and partners with Costco/Walmart to counter 9% market share loss amid U.S. pricing pressures and patent expirations. - The obesity drug

Bitget-RWA2025/11/06 08:30